Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.


Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: [Email]


Radiotherapy produces immune-promoting effects, which may be blunted by the delivery of corticosteroids (CS). We thus aimed to evaluate the impact of CS use on recurrence and survival outcomes of patients with early stage non-small-cell lung cancer treated with stereotactic ablative radiotherapy (SABR).


Corticosteroid,Early stage lung cancer,Immunotherapy,SABR,SBRT,